ETHICAL COMPLIANCE REPORT

WINDLAS BIOTECH

Sector:

Healthcare

Industry:

Drug Manufacturers - Specialty & Generic

Overall Compliance

compliant

PRIMARY BUSINESS FILTER
Pharmaceuticals
compliant
DEBT RATIO FILTER
0%
View Calculations
LIQUIDITY RATIO FILTER
4.9%
View Calculations
REVENUE RATIO FILTER
2%
View Calculations

Debt Ratio

The interest bearing debt should not exceed 31% of the total assets. This is to ensure that the company is not paying a significant portion of its assets as interest.

CALCULATION

\textbf{Debt Ratio:} \\[12pt] \dfrac{1090000.00}{6262060000.00} \times 100 = 0.00\%

FORMULA

\textbf{Debt Ratio:} \\[12pt] \dfrac{\text{Interest Bearing Debt}}{\text{Total Assets}} \times 100 \; \leq \; 30\%

Liquidity Ratio

The total liquid assets should not exceed 90% of the total assets. This is to ensure that trading this stock does not become similar to trading a currency.

4.9%

CALCULATION

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{309450000.00}{6262060000.00} \times 100 = 4.90\%

FORMULA

\textbf{Liquidity Ratio:} \\[12pt] \dfrac{\text{Total Liquid Assets}}{\text{Total Assets}} \times 100 \; \leq \; 90\%

Revenue Ratio

The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.

Non Compliant

Questionable

Compliant

CALCULATION

\textbf{Revenue Ratio:} \\[12pt] \dfrac{127870000.00}{6444210000.00} \times 100 = 2.00\%

FORMULA

\textbf{Revenue Ratio:} \\[12pt] \dfrac{\text{Unethical Segments}}{\text{Total Revenue}} \times 100 \; \leq \; 3\%

Segment	Compliance	Value
Pharmaceuticals	compliant	₹599.39
Export Sales	compliant	₹27.39
Sale of Services	compliant	₹2.11
Other Operating Income	compliant	₹2.07
Other Income	compliant	₹0.68
Net Gain on Sale of Investments	questionable	₹10.82
Interest income	non-compliant	₹1.97